Followers | 88 |
Posts | 8196 |
Boards Moderated | 0 |
Alias Born | 06/17/2013 |
Thursday, July 09, 2020 7:34:37 AM
Therapeutic Solutions International (TSOI) is focused on immune modulation
for the treatment of several specific diseases.
http://therapeuticsolutionsint.com/
TSOI Is On the Right To Try (RTT) Pathway w/ new therapies and adjuvants in these areas of study:
(According to the RTT Law , TSOI will decide which products below will be offered on this pathway)
Stage 1 - 4 Cancers (Tumor types) - Breast Cancer , Prostate Cancer w/ StemVacs Immunotherapy Platform https://stemvacs.com/ , BRS-001 http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/77635806/therapeutic-solutions-international-expands-adopti , NanoStilbeneTM , http://mynanostilbene.com/
Cancer Metabolic DeTox, https://www.globenewswire.com/news-release/2017/05/09/1076506/0/en/Therapeutic-Solutions-files-new-Patent-on-Targeting-the-Tumor-Microenvironment-through-Nutraceutical-Based-Immunoadjuvants.html
and IsoStilbene https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/77734511/therapeutic-solutions-international-releases-isos
Liver Cancer, Esophageal Cancer, Melanoma (w/ Ipilimumab) NanoStilbeneTM http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80371866/therapeutic-solutions-international-reports-its-na
Breast Cancer, Prostate Cancer, and Ovarian Cancer w/ Ozone therapy , and NanoStilbene https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78060284/therapeutic-solutions-international-reports-synerg
Prostate Cancer w/ NanoPSA https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80285424/therapeutic-solutions-international-develops-gluco
and NanoMyros https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80311774/therapeutic-solutions-international-develops-adjuv
Glioma / Brain Cancers https://therapeuticsolutionsint.com/?page_id=232 w/ NeuroStilbene , and Brain Cancer Therapeutics https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/77868683/therapeutic-solutions-international-inc-release
CTE / Military and Sports Brain Injuries - (Chronic Traumatic Encephalopathy) w/ JadiCell MSCs (Mesenchymal Stem Cells) https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80242706/therapeutic-solutions-international-obtains-exclus ,
Autologous Neurogenic Stem Cell Banking, http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/79022244/therapeutic-solutions-international-continues-to-e
sRNA augmented stem cells, http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78834511/therapeutic-solutions-international-expands-chroni
"Educated" Monocytes / Progenitors, https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/79095195/therapeutic-solutions-international-continues-to-e
and NeuroStilbene http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78538984/therapeutic-solutions-international-announces-cte
TBI / mTBI / bTBI (blast TBI) - (Traumatic Brain Injury / mild TBI) w/ JadiCell MSCs, https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80242706/therapeutic-solutions-international-obtains-exclus
and NeuroStilbene https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/77868683/therapeutic-solutions-international-inc-release
CRS - (Cytokine Release Syndrome) / Inflammation , Car-T sickness / Immunotherapy side effects w/ NanoStilbeneTM https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78326088/therapeutic-solutions-international-files-patent-o
Diabetes, Cardiovascular Disease, and Neurodegenerative Diseases w/ Projuvenol ® https://www.biomedreports.com/market-wire/259588-therapeutic-solutions-international-files-patent-covering-projuvenol(c)-and-its-active-ingredient-pterostilbene.html
Neurodegenerative Conditions / Oxidative Brain and Neural Disorders - MS (Multiple Sclerosis), Stroke / post Stroke recovery, and Alzheimers , w/ Alpha Lipoic Acid . https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/78013140/therapeutic-solutions-international-develops-micro
Elevated PSA Levels w/ NanoPSA https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80285424/therapeutic-solutions-international-develops-gluco
and NanoMyros https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80311774/therapeutic-solutions-international-develops-adjuv
RA - (Rheumatoid Arthritis) / Synovitis w/ NanoPSA https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80285424/therapeutic-solutions-international-develops-gluco
and NanoMyros https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/80311774/therapeutic-solutions-international-develops-adjuv
TNF (Tumor Necrosis Factor) / Atherosclerosis / TF (Tissue Factor) Elevations, Sepsis, Cardiovascular Disease, RA , Infection w/ NanoStilbene PKE https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/79295986/therapeutic-solutions-international-continues-to-r
Covid 19, SARS, ARDS, Breast Cancer, RA, Depression w/ QuadraMune, https://quadramune.com/ , http://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-pk-TSOI/stock-news/82657747/therapeutic-solutions-international-reports-reduct
and NLRP3 Trifecta https://www.youcanordernow.com/NLRP3-Trifecta_p_33.html
Covid 19 w, StemVacs 2 https://www.prnewswire.com/news-releases/therapeutic-solutions-international-submits-publication-on-stemvacs-preclinical-data-supporting-covid-19-indication-301089133.html
TSOI Right To Try Info & TSOI RTT news:
Therapeutic Solutions International to Provide Patients Access to StemVacs Cancer Immunotherapy through Newly Passed Right to Try Law 5/31/18
https://www.globenewswire.com/news-release/2018/05/31/1514822/0/en/Therapeutic-Solutions-International-to-Provide-Patients-Access-to-StemVacs-Cancer-Immunotherapy-through-Newly-Passed-Right-to-Try-Law.html
Therapeutic Solutions International Announces the Appointment of
James Veltmeyer, MD as Chief Medical Officer 6/18/18
https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-international-inc-pc-TSOI/stock-news/77684969/therapeutic-solutions-international-announces-the
TSOI CEO Tim G Dixon receiving the Right To Try Leadership Award (Video) 12/19/18
https://www.facebook.com/tsoihome/videos/2083466298358398/
Therapeutic Solutions International Collaborates with Right to Try Foundation on Novel Means of Protecting Patients While Hyper-accelerating Drug Development
Company Plans to Advance its Phase I Cancer Immunotherapy StemVacs™ to US Patients 8/5/19
https://www.globenewswire.com/news-release/2019/08/05/1896899/0/en/Therapeutic-Solutions-International-Collaborates-with-Right-to-Try-Foundation-on-Novel-Means-of-Protecting-Patients-While-Hyper-accelerating-Drug-Development.html
FDA Right to Try info for patients
https://www.fda.gov/ForPatients/Other/ucm625115.htm
Recent TSOI News
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/31/2024 08:51:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 04:47:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 12:46:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 12:44:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/30/2024 06:46:26 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 04:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 10:03:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:15:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:12:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:16:15 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/08/2024 05:15:25 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:34:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 08:42:55 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/17/2024 11:15:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/04/2024 09:03:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 07:44:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:39:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:17:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:13:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 06:50:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 05:44:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:24:52 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 11:10:01 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM